Clinical Trials Directory

Trials / Unknown

UnknownNCT03485560

Revitalization of Damaged Skin Due to Chronic Skin Diseases

Revitalization of Damaged Sking Due to Chronic Skin Diseases

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Ace Cells Lab Limited · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Chronic skin disease lead to skin damage and disfiguring to the patient skin. Sometimes, achieving normal skin is not possible by the normal traditional treatment, this study is focusing on use of ACE CSD formula which is mixture of natural peptides and herbs. the main aim is to restore the normal skin appearance for the patient and control the episodes of flare.

Detailed description

Psoriasis is a chronic, immune mediated (type 2 and type 17) chronic skin disease. The production of the immune proteins that leads to continuous inflammatory mediated process. The result of chronic inflammation is they hyper keratotic layer of skin which gets attacks of atopic dermatitis leading to symptoms of itching, pruritis and in situ bleeding. ACE CSD, with the multiple factors that mediates the immune response and control the protein receptors, in addition to the multiple regeneration peptides that are specifically extracted from healthy skin of newly born sheep; in addition to multiple Chinese herbs that contains different anabolic factors was tested to be able to regenerate the damaged skin and locally modulate the immunity reactions so the skin can regenerate fully to replace the damaged skin with normal healthy skin.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTACE CSDTopical application of the ACE CSD 4 times daily.

Timeline

Start date
2018-05-01
Primary completion
2018-11-01
Completion
2019-01-01
First posted
2018-04-02
Last updated
2018-04-02

Locations

2 sites across 2 countries: Serbia, United Kingdom

Source: ClinicalTrials.gov record NCT03485560. Inclusion in this directory is not an endorsement.